Gastric cancer and lung cancer
Conditions
Interventions
Group 1:TP+FMT
Group 2:SOX+FMT
Sponsors
Changzhou Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. (1) Gastric cancer group: unresectable advanced gastric/gastroesophageal carcinoma confirmed by histopathological age and/or cytology; (2) lung cancer group: unresectable advanced non-small cell lung cancer confirmed by histopathological age and/or cytology; 2. ECOG score 0-1; 3. There has been no systemic intravenous anti-tumor therapy in the past; 4. Aged 18-90 years; 5. Patients have at least one measurable lesion according to RECIST 1.1 standard; 6. Estimated survival time >= 4 months.
Exclusion criteria
Exclusion criteria: 1. Unable to cooperate with mental illness; 2. Have a history of immunodeficiency, or suffer from other acquired or congenital immunodeficiency diseases, or have a history of organ transplant; 3. Use large doses of glucocorticoids or immune transplants within 4 weeks; 4. Complicated with other malignant tumors; 5. Patients who participate in other clinical trials within 4 weeks; 6. Patients with infectious pneumonia, non-infectious pneumonia, interstitial pneumonia and other patients who need to use corticosteroids; 7. Have a history of severe chronic autoimmune diseases, such as systemic lupus erythematosus; a history of inflammatory bowel diseases such as ulcerative enteritis and Crohn's disease; a history of chronic diarrheal diseases such as irritable bowel syndrome; a history of sarcoidosis or tuberculosis; 8. Patients who do not follow the doctor's advice, do not take medicine in accordance with the regulations, or have incomplete data, such as those who can affect the judgment of efficacy or safety; 9. According to the judgment of the researchers, there are serious hazards to the safety of patients or concomitant diseases that affect the completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| safety; | — |
Countries
China
Contacts
Public ContactJiang Hua
Changzhou Second People's Hospital
Outcome results
None listed